Elanco closes $444M purchase of biopharma co.August 31, 2021Elanco Animal Health has expanded its reach into the veterinary dermatology market with the $444-million acquisition of biopharma company, Kindred Biosciences.
SPONSORED CONTENTHelp save more lives with this parvovirus innovationOur Canine Parvovirus Monoclonal Antibody offered a 93% real-world survival rate for puppies afflicted with parvovirus.1 Discover the future of parvo treatment today! + Read More
Elanco acquires biopharma co. in $440M dealJune 16, 2021A major player in the global animal health industry has expanded its reach into the veterinary dermatology market with the purchase of a biopharmaceutical company.
Keep more flea and tick preventive purchases in-clinicMarch 20, 2019When pet owners needed to purchase parasite control products, they traditionally went to their local veterinarian. However, the influx of retail businesses (both online and brick and mortar) competing in this market has created a financial feasting frenzy on clinic profits. "We have moved from having a near monopoly on the sale of flea/tick products to the current situation where less than half of clients are now purchasing their flea/tick products from their veterinarian," …
U.S. and Canadian pet owners more likely buy pet insurance regardless of incomeJanuary 17, 2019More than half of pet owners in the U.S. and Canada are willing to purchase insurance for their animals regardless of their income.
